Ocular Therapeutix Soars Amid Frenzied Takeover Whispers: Is Amgen Eyeing a Biotech Gem?
A Major Setback for Amgen: Bemarituzumab's Gastric Cancer Ambitions Dim as Final Data Fails to Impress
A Golden Ticket to Breakthrough: Singzyme’s Bioconjugation Platform Set to Revolutionize Medicine